Ascentage Pharma Group International American Depository Shares (AAPG)
Stock · NASDAQ · Health Care
$15.27as of 10/16/2026
Price chart
Active signals
AAPG Signal Track Record
How signals performed across all stocks →What AAPG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 8 | +3.8% | 63% | September 16, 2026 |
| Any 20-session window (baseline) | -7.6% | 23% |
Computed by MarketWall from daily closing prices since November 7, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About AAPG
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic ma…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 828
- Website
- www.ascentage.cn/
Fundamentals
- 1-day range
- $14.47$14.93
- Market cap
- $1.60B
- P/E (trailing)
- —
- P/E (forward)
- -22.59
- EPS (trailing)
- $-3.95
- Dividend yield
- —
- Beta
- 0.67
- Avg. volume
- 6.4K
Forecasts
10 analyst ratings
Ascentage Pharma Group International American Depository Shares Competitors
Chosen by industry and closest market cap.
- AAPGAscentage Pharma Group International American Depository Shares$15.37▲ 4.63%Market cap $1.60BP/E —$27.12$75.1
- TYRATyra Biosciences Inc. Common Stock$18.52▼ 2.73%Market cap $1.61BP/E —$12.96$40.65
- TRAXFirst Tracks Biotherapeutics Inc. Ordinary Shares$34.46▼ 4.38%Market cap $1.58BP/E —$14.72$49.91
- MRVIMaravai LifeSciences Holdings Inc. Class A Common Stock$6.79▼ 3.96%Market cap $1.61BP/E —$2.55$9.42
- ANABAnaptysBio Inc. Common Stock$46.61▼ 4.31%Market cap $1.62BP/E 7.14$20.18$72.36
- INVAInnoviva Inc. Common Stock$20.78▼ 0.38%Market cap $1.56BP/E 4.25$16.52$25.15
- ZYMEZymeworks Inc. Common Stock$25.03▼ 2.80%Market cap $1.69BP/E —$16$31.34
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AAPG Ascentage Pharma Group International American Depository Shares | $1.60B | — | $15.37 | ▲ 4.63% | $27.12$75.1 |
| TYRA Tyra Biosciences Inc. Common Stock | $1.61B | — | $18.52 | ▼ 2.73% | $12.96$40.65 |
| TRAX First Tracks Biotherapeutics Inc. Ordinary Shares | $1.58B | — | $34.46 | ▼ 4.38% | $14.72$49.91 |
| MRVI Maravai LifeSciences Holdings Inc. Class A Common Stock | $1.61B | — | $6.79 | ▼ 3.96% | $2.55$9.42 |
| ANAB AnaptysBio Inc. Common Stock | $1.62B | 7.14 | $46.61 | ▼ 4.31% | $20.18$72.36 |
| INVA Innoviva Inc. Common Stock | $1.56B | 4.25 | $20.78 | ▼ 0.38% | $16.52$25.15 |
| ZYME Zymeworks Inc. Common Stock | $1.69B | — | $25.03 | ▼ 2.80% | $16$31.34 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Zhai Yifan · May 21, 2026 · Option Exercise92.7K
- Yang Dajun · May 21, 2026 · Option Exercise92.7K
- Yang Dajun · May 21, 2026 · Option Exercise95.6K
- Zhai Yifan · May 21, 2026 · Option Exercise95.6K
- Zhai Yifan · May 20, 2026 · Grant298.2K
- Zhai Yifan · May 20, 2026 · Grant298.2K
- Zhai Yifan · May 20, 2026 · Grant95.6K
- Zhai Yifan · May 20, 2026 · Grant92.7K
- Zhai Yifan · May 20, 2026 · Grant103.4K
- Zhai Yifan · May 20, 2026 · Grant215.0K
- Zhai Yifan · May 20, 2026 · Grant215.0K
- Zhai Yifan · May 20, 2026 · Grant103.4K
- Yang Dajun · May 20, 2026 · Grant92.7K
- Yang Dajun · May 20, 2026 · Grant103.4K
- Yang Dajun · May 20, 2026 · Grant215.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 30.2K
- Total value held
- $721.7K
- Institutional holders
- 7
- Unknown16.1K
- Unknown13.0K
- Unknown518
- Unknown498
- Unknown124
- Unknown24
- Unknown6
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
AAPG shares dip in pre‑market as broader market slides
AAPG American Depository Shares fell in Friday’s pre‑market session. The decline came as the market reacted to Nike’s mixed first‑quarter earnings, which pushed several large stocks lower. The move occurs while the stock is near its $16.96 support level and the RSI is around 41, indicating modest momentum weakness.
AAPG shares dip in pre‑market as broader market slides. AAPG American Depository Shares fell in Friday’s pre‑market session. The decline came as the market reacted to Nike’s mixed first‑quarter earnings, which pushed several large stocks lower. The move occurs while the stock is near its $16.96 support level and the RSI is around 41, indicating modest momentum weakness.